Allianz Asset Management’s Vir Biotechnology VIR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.65M | Buy |
327,700
+19,000
| +6% | +$95.8K | ﹤0.01% | 1155 |
|
2025
Q1 | $2M | Buy |
308,700
+136,751
| +80% | +$886K | ﹤0.01% | 1128 |
|
2024
Q4 | $1.26M | Buy |
171,949
+99,593
| +138% | +$731K | ﹤0.01% | 1200 |
|
2024
Q3 | $542K | Buy |
+72,356
| New | +$542K | ﹤0.01% | 1399 |
|
2023
Q2 | – | Sell |
-22,394
| Closed | -$521K | – | 1759 |
|
2023
Q1 | $521K | Buy |
+22,394
| New | +$521K | ﹤0.01% | 1424 |
|
2022
Q2 | – | Sell |
-30,218
| Closed | -$777K | – | 1897 |
|
2022
Q1 | $777K | Buy |
30,218
+418
| +1% | +$10.7K | ﹤0.01% | 1648 |
|
2021
Q4 | $1.24M | Buy |
29,800
+5,805
| +24% | +$242K | ﹤0.01% | 1530 |
|
2021
Q3 | $1.04M | Sell |
23,995
-2,700
| -10% | -$117K | ﹤0.01% | 1554 |
|
2021
Q2 | $1.26M | Hold |
26,695
| – | – | ﹤0.01% | 1419 |
|
2021
Q1 | $1.37M | Buy |
26,695
+2,395
| +10% | +$123K | ﹤0.01% | 1373 |
|
2020
Q4 | $651K | Buy |
+24,300
| New | +$651K | ﹤0.01% | 1561 |
|